http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-199800464-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 1997-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-199800464-A1 |
| titleOfInvention | SYNERGISTIC IMMUNOSUPRESSOR COMPOSITION CONTAINING 2,2'-BI-1H-PYRROL COMPOUND |
| abstract | A substance containing: (a) an immunosuppressive agent (A) and (b) at least one immunosuppressive 2,2'-bi-1H-pyrrole compound (B), having the formula (I) in which R1 is hydrogen, phenyl, an alkyl group with 1-20 carbon atoms or an alkenyl group with 2-20 carbon atoms, wherein the alkyl and alkenyl groups can be unsubstituted or substituted with one to three substituents, the same or different, independently selected from halogen, alkoxy groups with 1-6 carbon atoms, hydroxy, aryl or aryloxy groups; R 2 is is hydrogen, an alkyl group with 1-6 carbon atoms, a cyano group, a carboxy group, or (C-Salkoxy) carbonyl; R 2 is a halogen, hydroxy group, or an alkoxy group with 1-11 carbon atoms, unsubstituted or substituted with phenyl; -6 carbon atoms or phenyl; each of R 8 and R 8, which are the same or different, independently represent hydrogen, an alkanoyl group with 2-20 carbon atoms, an alkanoyl group with 3-20 carbon atoms, a phenyl group, an alkyl group with 1-20 carbon atoms or alkenyl group with 2- 20 carbon atoms; or two of R, R and R, taken together, form a polymethylene chain with 4 to 12 carbon atoms, which can be unsubstituted or substituted by an alkyl group with 1 to 12 carbon atoms, an alkenyl group with 2 to 12 carbon atoms or an alkylidene group with 1 -12 carbon atoms; or a pharmaceutically acceptable salt thereof; as a combined preparation for simultaneous, separate or sequential use in immunosuppressive therapy; the abovementioned preparation has an increased immunosuppressive activity compared to preparations containing either |
| priorityDate | 1996-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.